Eli Samaha - 20 Sep 2022 Form 3 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role: 10%+ Owner
Signature: Eli Samaha
Issuer symbol: TBPH
Transactions as of: 20 Sep 2022
Net transactions value: $0
Form type: 3
Filing time: 21 Oct 2022, 19:35:50 UTC
Previous filing: 28 Jun 2022
Next filing: 30 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TBPH	COM						7,012,226	20 Sep 2022	See footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person in the funds. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial ownership of such securities.

Content

These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person in the funds. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial ownership of such securities.